| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |